-+ 0.00%
-+ 0.00%
-+ 0.00%

Oruka Therapeutics General Counsel Paul Quinlan Reports Sale of 9,000 Common Shares for $853,985.65

PUBT·11/20/2026 21:52:08
Oruka Therapeutics General Counsel Paul Quinlan Reports Sale of 9,000 Common Shares for $853,985.65
  • Oruka Therapeutics General Counsel Paul T. Quinlan sold 9,000 common shares on Nov. 20, 2026.
  • The sales carried weighted-average prices ranging from $94.0485 to $96.60 per share.
  • Quinlan also exercised employee warrants to acquire 9,000 common shares at $7.80 each.
  • Following the transactions, he directly held 29,995 common shares and 61,996 employee warrants.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000120), on November 20, 2026, and is solely responsible for the information contained therein.